The FDA in January asked Amgen to pull Tavneos from the market, citing liver toxicity issues that affected the drug’s overall ...

Amgen Inc. (NASDAQ:AMGN) is one of the best pharma stocks to invest in now. Amgen Inc. (NASDAQ:AMGN) announced on March 28 that Repatha® lowered the risk of first major adverse cardiovascular events ...

Zai Lab (ZLAB) stock jumps as the company announces a global clinical trial collaboration with Amgen (AMGN). Read more here.

Amgen’s rare disease drug Tavneos is under mounting regulatory scrutiny, with the FDA warning of serious liver injuries, ...

By Puyaan Singh March 31 (Reuters) - The U.S. Food and Drug Administration on Tuesday said it has identified cases of liver ...

Amgen drug under FDA review Tavneos is linked to 76 liver injury cases including eight deaths; FDA advises liver monitoring ...

Zai Lab and Amgen will collaborate on a clinical trial to evaluate a Zai Lab lung cancer therapy. Under the agreement, Amgen will sponsor a global phase 1b study to evaluate the safety and efficacy of ...

In late March 2026, the FDA warned of severe liver injuries, including vanishing bile duct syndrome, linked to ...

Roche's strong drug growth is offsetting legacy declines, while strategic deals aim to reshape its portfolio amid biosimilar pressure and FX headwinds.

The Irish arm of bio-pharmaceutical giant Amgen has invested $407m (€353.3m) on capital expenditure on its Dun Laoghaire ...

The FDA said it has identified 76 cases of drug-induced liver injuries with reasonable evidence of being causally linked to ...

Repatha is the Only PCSK9 Inhibitor to Significantly Reduce the Risk of First CV Events in High-Risk Primary Prevention VESALIUS-CV Subgroup Findings Reinforce Benefit ...